Fresenius SE & Co KGaA (FRA:FRE)‘s stock had its “buy” rating restated by investment analysts at DZ Bank in a research note issued on Friday, Borsen Zeitung reports. Other analysts also recently

The Best Biotech Stocks To Buy Now

10:57pm, Friday, 06'th Mar 2020
Healthcare is a top sector in our weekly ranking. Why Ironwood Pharmaceuticals and ACADIA Pharmaceuticals are among the highest-rated biotech companies in our u
Fresenius Medical price target lowered to EUR 89.70 from EUR 89.95 at Berenberg Berenberg FMS
Q4 2019 ANI Pharmaceuticals Inc Earnings Call
Portland, OR, March 04, 2020 -- The Nephrology Devices Industry generated $12.51 billion in 2019 and is estimated to garner $16.42 billion by 2026, growing at a CAGR of 4.0%.

Global Urological Catheters Industry

02:28pm, Wednesday, 04'th Mar 2020
New York, March 04, 2020 -- Reportlinker.com announces the release of the report "Global Urological Catheters Industry" - https://www.reportlinker.com/p05151475/?utm_source=GNW.
RBC Capital analyst Frank Morgan maintained a Buy rating on LHC Group (LHCG) on March 1 and set a price target of $180.00. The company's shares closed
There's a lot to be optimistic about in the Services sector as 3 analysts just weighed in on Acadia Healthcare (ACHC), American Tower (AMT) and AutoZone
Barclays restated their neutral rating on shares of Fresenius SE & Co KGaA (FRA:FRE) in a research report report published on Tuesday, Borsen Zeitung reports. Several other research analysts have also
Fresenius SE & Co KGaA (FRA:FRE) has been given a €51.00 ($59.30) target price by equities researchers at Morgan Stanley in a report issued on Monday, Borsen Zeitung reports. The firm presently has
Fresenius SE & Co KGaA (FRA:FRE) has been assigned a consensus recommendation of “Buy” from the sixteen research firms that are presently covering the firm, Marketbeat reports. Eight equities rese
The global chemotherapy devices market is was valued at 152.80 million USD in 2017 and is anticipated to grow at a significant rate during the forecast period. Chemotherapy devices are used to slow do
LAKE FOREST, Ill., Feb. 26, 2020 -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty pharmaceutical company, today announced its financial results for the quarter and year ended.
Nord/LB set a €58.00 ($67.44) price target on Fresenius SE & Co KGaA (FRA:FRE) in a research note released on Tuesday morning, Borsen Zeitung reports. The firm currently has a buy rating on the stoc
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE